This study showed that Lifebox's Clean Cut program improved infection prevention standards to reduce SSI without infrastructure expenses or resource investments.
This study demonstrated that pulse oximetry is a cost–effective intervention for low-income settings.
This study indicates that pulse oximetry is widely accepted as essential monitoring for safe anesthesia, yet is frequently unavailable in resource-limited settings.
This study shows that the Lifebox pulse oximeter detects hypoxia in healthy volunteers at a degree of accuracy and bias that is comparable to FDA-approved pulse oximeters made by major manufacturers.
This study showed the estimated number of operating theatres ranged from 1·0 (95% CI 0·9–1·2) per 100 000 people in west sub-Saharan Africa to 25·1 (20·9–30·1) per 100 000 in eastern Europe.